Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anti-HIV drug update

    Project Inform Perspective
    |May 29, 2003
    PubMed
    Summary

    New anti-HIV drugs show slow but steady progress, with some offering true second-generation advancements over current therapies. Others provide minimal improvements, based on recent studies including the 7th Conference on Retroviruses and Opportunistic Infections.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same journal

    Everything antiretroviral: 5th IAS conference, Cape Town, South Africa.

    Project Inform perspective·2012
    Same journal

    Well implemented, President Obama's national HIV/AIDS strategy is precisely what is needed to further control HIV/AIDS.

    Project Inform perspective·2011
    Same journal

    Finding health care; preparing for the future.

    Project Inform perspective·2011
    Same journal

    Protecting people with HIV in the California budget.

    Project Inform perspective·2010
    Same journal

    Current drugs in clinical study.

    Project Inform perspective·2010
    Same journal

    HIV treatment information.

    Project Inform perspective·2010

    Area of Science:

    • Virology
    • Pharmacology
    • Infectious Diseases

    Background:

    • Ongoing research into novel anti-HIV drug classes is yielding incremental advancements.
    • The development pipeline includes therapies with varying degrees of improvement over existing treatments.

    Discussion:

    • Several new anti-HIV drugs are nearing potential approval, representing the next wave of HIV treatment options.
    • The efficacy and novelty of these drugs differ, with some offering significant therapeutic advantages.

    Key Insights:

    • New anti-HIV medications are progressing through development, categorized by their potential to improve upon current HIV therapies.
    • Recent data, including findings from the 7th Conference on Retroviruses and Opportunistic Infections, inform the evaluation of these emerging drugs.

    Outlook:

    • The future of HIV treatment will likely incorporate a mix of established and novel drug classes.
    • Continued research and clinical trials are essential to fully characterize the benefits of these second-generation anti-HIV therapies.

    Related Experiment Videos